Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05472064 · ClinicalTrials.gov registry record
Design of Chatbot Persona for Breast Cancer Screening Outreach Among Black Women
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 550
- Enrollment target
NCT05472064: Completed study, sponsored by University of Washington.
NCT05472064 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 550 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05472064 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 550 participants
- Enrollment target
Study Summary
Breast cancer screening disparities among Black women persist despite health system recognition and outreach. However, current evidence on how to tailor and optimize implementation strategies for breast cancer screening outreach is limited. The proposed study is part of a larger project to design a chatbot for breast cancer screening outreach to Black women and will focus on optimizing the chatbot persona. Using the Multiphase Optimization Strategy (MOST) framework, the investigators will conduct a randomized factorial experiment to assess the individual components of chatbot persona for breast cancer screening and identify which components have the greatest effect on trust and engagement for Black women. This information will guide the design of an optimized chatbot intervention that achieves the primary outcomes.
Primary Outcome
The human-computer trust scale assesses user trust, which is based on similar constructs of trust (benevolence, competence, reciprocity, perceived risk). 7 of the 12 items were selected which use a 5-point Likert scale from 'Strongly disagree' to 'Strongly agree'.
Interventions
- OTHER Persona: Primary care doctor
- OTHER Persona: Breast cancer survivor
- OTHER Communication Style: Direct
- OTHER Communication Style: Indirect
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2022-08-22 |
| Est. Completion | 2022-12-27 |
What the finished NCT05472064 record still lists
NCT05472064 is an observational study that tracks outcomes without assigning an intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which Persona: Primary care doctor is the first listed.
NCT05472064 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05472064 about?
NCT05472064 is a clinical study titled "Design of Chatbot Persona for Breast Cancer Screening Outreach Among Black Women". Breast cancer screening disparities among Black women persist despite health system recognition and outreach. However, current evidence on how to tailor and optimize implementation strategies for breast cancer screening outreach is limited. The proposed study is part of a larger project to design a ...
What is the current status of trial NCT05472064?
This trial is currently completed. The enrollment target is 550 participants. The study started on 2022-08-22. Estimated completion is 2022-12-27.
What interventions are being tested in trial NCT05472064?
The interventions under investigation include: Persona: Primary care doctor (OTHER), Persona: Breast cancer survivor (OTHER), Communication Style: Direct (OTHER), Communication Style: Indirect (OTHER).
Who is sponsoring clinical trial NCT05472064?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI